| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 59762-0407-4 | 59762-0407 | HUMAN PRESCRIPTION DRUG | Risedronate Sodium | risedronate sodium | TABLET, DELAYED RELEASE | ORAL | 20180302 | N/A | NDA AUTHORIZED GENERIC | NDA022560 | Greenstone LLC | RISEDRONATE SODIUM HEMI-PENTAHYDRATE; RISEDRONATE SODIUM MONOHYDRATE | 30.1 mg/1; 4.9 mg/1 | 1 BLISTER PACK in 1 CARTON (59762-0407-4) / 4 TABLET, DELAYED RELEASE in 1 BLISTER PACK |
| 0430-0979-03 | 0430-0979 | HUMAN PRESCRIPTION DRUG | Atelvia | risedronate sodium | TABLET, DELAYED RELEASE | ORAL | 20101201 | N/A | NDA | NDA022560 | Allergan, Inc. | RISEDRONATE SODIUM HEMI-PENTAHYDRATE; RISEDRONATE SODIUM MONOHYDRATE | 30.1 mg/1; 4.9 mg/1 | 4 TABLET, DELAYED RELEASE in 1 DOSE PACK (0430-0979-03) |